Gene · 3635
Papers3,499
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,499
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Brain alarm by self-extracellular nucleic acids: from neuroinflammation to neurodegeneration. | J Biomed Sci | 2023 | 37550658 | PubTator, text mining | PubMed |
| CD31 signaling promotes the detachment at the uropod of extravasating neutrophils allowing their migration to sites of inflammation. | Elife | 2023 | 37549051 | PubTator, text mining | PubMed |
| Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAM. | bioRxiv | 2023 | 37547005 | PubTator, text mining | PubMed |
| Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond. | Front Immunol | 2023 | 37539051 | PubTator, text mining | PubMed |
| Case report: Clinicopathological and molecular characteristics of pediatric-type follicular lymphoma. | Front Pediatr | 2023 | 37539011 | PubTator, text mining | PubMed |
| Phosphoinositides and intracellular calcium signaling: novel insights into phosphoinositides and calcium coupling as negative regulators of cellular signaling. | Exp Mol Med | 2023 | 37524877 | PubTator, text mining | PubMed |
| Variable-Step Multiscale Fuzzy Dispersion Entropy: A Novel Metric for Signal Analysis. | Entropy (Basel) | 2023 | 37509944 | PubTator, text mining | PubMed |
| Nuclear Phosphoinositides as Key Determinants of Nuclear Functions. | Biomolecules | 2023 | 37509085 | PubTator, text mining | PubMed |
| TIGIT, a novel immune checkpoint therapy for melanoma. | Cell Death Dis | 2023 | 37495610 | PubTator, text mining | PubMed |
| Sequence variants contributing to dysregulated inflammatory responses across keratoconic cone surface in adolescent patients with keratoconus. | Front Immunol | 2023 | 37483635 | PubTator, text mining | PubMed |
| IL-10 Dysregulation in Bipolar Disorder: Potential Mechanisms and Treatment Implications. | Indian J Psychol Med | 2023 | 37483581 | PubTator, text mining | PubMed |
| Confirmed Synergy Between the ɛ4 Allele of Apolipoprotein E and the Variant K of Butyrylcholinesterase as a Risk Factor for Alzheimer's Disease: A Systematic Review and Meta-Analysis. | J Alzheimers Dis Rep | 2023 | 37483326 | PubTator, text mining | PubMed |
| Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals. | J Alzheimers Dis | 2023 | 37482996 | PubTator, text mining | PubMed |
| LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis. | Nat Commun | 2023 | 37481670 | PubTator, text mining | PubMed |
| Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges. | Mil Med Res | 2023 | 37460924 | PubTator, text mining | PubMed |
| Investigation of Potential Drug Targets for Cholesterol Regulation to Treat Alzheimer's Disease. | Int J Environ Res Public Health | 2023 | 37444065 | PubTator, text mining | PubMed |
| SHIP1 Is Present but Strongly Downregulated in T-ALL, and after Restoration Suppresses Leukemia Growth in a T-ALL Xenotransplantation Mouse Model. | Cells | 2023 | 37443832 | PubTator, text mining | PubMed |
| TFF3 promotes clonogenic survival of colorectal cancer cells through upregulation of EP4 via activation of STAT3. | Transl Cancer Res | 2023 | 37434683 | PubTator, text mining | PubMed |
| The inhibitory receptor Siglec-G controls the severity of chronic lymphocytic leukemia. | EMBO Rep | 2023 | 37424400 | PubTator, text mining | PubMed |
| Mechanisms controlling membrane recruitment and activation of the autoinhibited SHIP1 inositol 5-phosphatase. | J Biol Chem | 2023 | 37423304 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3635/papers?page=13